International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan
Conditions
Interventions
- DRUG: Azilsartan Medoxomil
Sponsor
Takeda